arGentis Pharmaceuticals, LLC Signs Agreement with LifeCyte to Develop cGMP Facility

MEMPHIS, Tenn.--(BUSINESS WIRE)--arGentis™ Pharmaceuticals, LLC announced today that it had signed an agreement with LifeCyte Inc., a Memphis-based biopharmaceutical services company, to assist in the design and development of a dedicated current Good Manufacturing Practices (cGMP) facility that will purify arGentis’ collagen products portfolio.

MORE ON THIS TOPIC